Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
IUBMB CommentsThe enzyme, isolated from the bacterium Streptomyces venezuelae, is involved in the biosynthesis of the antibiotic chloramphenicol. It contains a carboxylate-bridged binuclear non-heme iron cluster. The components of the native electron chain have not been identified, although the immediate donor is likely to be an iron-sulfur protein. The reaction mechanism involves formation of an extremely stable peroxo intermediate that catalyses three individual two-electron oxidations via a hydroxylamine and a nitroso intermediates without releasing the intermediates. cf. EC 1.14.99.68, 4-aminobenzoate N-oxygenase.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
alpha-N-dichloroacetyl-p-aminophenylserinol,acceptor:oxygen oxidoreductase (N-hydroxylating)
The enzyme, isolated from the bacterium Streptomyces venezuelae, is involved in the biosynthesis of the antibiotic chloramphenicol. It contains a carboxylate-bridged binuclear non-heme iron cluster. The components of the native electron chain have not been identified, although the immediate donor is likely to be an iron-sulfur protein. The reaction mechanism involves formation of an extremely stable peroxo intermediate that catalyses three individual two-electron oxidations via a hydroxylamine and a nitroso intermediates without releasing the intermediates. cf. EC 1.14.99.68, 4-aminobenzoate N-oxygenase.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(1R,2R)-(-)-2-(N-dichloroacetyl)-amino-1-(4-aminophenyl)-1,3-propanediol + reduced phenazine ethosulfate + 2 O2
?
(1R,2R)-(-)-2-(N-dichloroacetyl)-amino-1-(4-aminophenyl)-1,3-propanediol + reduced phenazine ethosulfate + 2 O2
chloramphenicol + phenazine ethosulfate + 2 H2O
(1R,2R)-(-)-2-(N-dichloroacetyl)-amino-1-(4-aminophenyl)-1,3-propanediol + reduced phenazine methosulfate + 2 O2
chloramphenicol + phenazine methosulfate + 2 H2O
4-aminobenzoate + reduced phenazine methosulfate + 2 O2
4-nitrobenzoate + phenazine methosulfate + 2 H2O
4-aminophenol + reduced phenazine methosulfate + 2 O2
4-nitrophenol + phenazine methosulfate + 2 H2O
L-4-aminophenylalanine + reduced phenazine methosulfate + 2 O2
L-4-nitrophenylalanine + phenazine methosulfate + 2 H2O
N-[(1R,2R)-1-(4-aminophenyl)-1,3-dihydroxypropan-2-yl]-2,2-dichloroacetamide + reduced phenazine methosulfate + 2 O2
chloramphenicol + phenazine methosulfate + 2 H2O
additional information
?
-
(1R,2R)-(-)-2-(N-dichloroacetyl)-amino-1-(4-aminophenyl)-1,3-propanediol + reduced phenazine ethosulfate + 2 O2
?
-
-
-
?
(1R,2R)-(-)-2-(N-dichloroacetyl)-amino-1-(4-aminophenyl)-1,3-propanediol + reduced phenazine ethosulfate + 2 O2
?
-
-
-
?
(1R,2R)-(-)-2-(N-dichloroacetyl)-amino-1-(4-aminophenyl)-1,3-propanediol + reduced phenazine ethosulfate + 2 O2
chloramphenicol + phenazine ethosulfate + 2 H2O
-
-
-
?
(1R,2R)-(-)-2-(N-dichloroacetyl)-amino-1-(4-aminophenyl)-1,3-propanediol + reduced phenazine ethosulfate + 2 O2
chloramphenicol + phenazine ethosulfate + 2 H2O
-
-
-
?
(1R,2R)-(-)-2-(N-dichloroacetyl)-amino-1-(4-aminophenyl)-1,3-propanediol + reduced phenazine methosulfate + 2 O2
chloramphenicol + phenazine methosulfate + 2 H2O
-
-
-
?
(1R,2R)-(-)-2-(N-dichloroacetyl)-amino-1-(4-aminophenyl)-1,3-propanediol + reduced phenazine methosulfate + 2 O2
chloramphenicol + phenazine methosulfate + 2 H2O
-
-
-
?
4-aminobenzoate + reduced phenazine methosulfate + 2 O2
4-nitrobenzoate + phenazine methosulfate + 2 H2O
-
-
-
?
4-aminobenzoate + reduced phenazine methosulfate + 2 O2
4-nitrobenzoate + phenazine methosulfate + 2 H2O
-
-
-
?
4-aminophenol + reduced phenazine methosulfate + 2 O2
4-nitrophenol + phenazine methosulfate + 2 H2O
-
-
-
?
4-aminophenol + reduced phenazine methosulfate + 2 O2
4-nitrophenol + phenazine methosulfate + 2 H2O
-
-
-
?
L-4-aminophenylalanine + reduced phenazine methosulfate + 2 O2
L-4-nitrophenylalanine + phenazine methosulfate + 2 H2O
-
-
-
?
L-4-aminophenylalanine + reduced phenazine methosulfate + 2 O2
L-4-nitrophenylalanine + phenazine methosulfate + 2 H2O
-
-
-
?
N-[(1R,2R)-1-(4-aminophenyl)-1,3-dihydroxypropan-2-yl]-2,2-dichloroacetamide + reduced phenazine methosulfate + 2 O2
chloramphenicol + phenazine methosulfate + 2 H2O
-
-
-
?
N-[(1R,2R)-1-(4-aminophenyl)-1,3-dihydroxypropan-2-yl]-2,2-dichloroacetamide + reduced phenazine methosulfate + 2 O2
chloramphenicol + phenazine methosulfate + 2 H2O
-
-
-
?
additional information
?
-
CmlI peroxo reacts with a range of arylamine substrates by an apparent second-order process. Chloramphenicol is efficiently produced from the free arylamine precursor. No substrate: L-4-aminophenylalanine
-
-
-
additional information
?
-
no acceptor: flavin mononucleotide. The reaction shows a biphasic behavior, with a fast step consuming significant amounts of substrate within 15 s, and a slower step afterward
-
-
-
additional information
?
-
CmlI peroxo reacts with a range of arylamine substrates by an apparent second-order process. Chloramphenicol is efficiently produced from the free arylamine precursor. No substrate: L-4-aminophenylalanine
-
-
-
additional information
?
-
no acceptor: flavin mononucleotide. The reaction shows a biphasic behavior, with a fast step consuming significant amounts of substrate within 15 s, and a slower step afterward
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(1R,2R)-(-)-2-(N-dichloroacetyl)-amino-1-(4-aminophenyl)-1,3-propanediol + reduced phenazine ethosulfate + 2 O2
?
(1R,2R)-(-)-2-(N-dichloroacetyl)-amino-1-(4-aminophenyl)-1,3-propanediol + reduced phenazine methosulfate + 2 O2
chloramphenicol + phenazine methosulfate + 2 H2O
(1R,2R)-(-)-2-(N-dichloroacetyl)-amino-1-(4-aminophenyl)-1,3-propanediol + reduced phenazine ethosulfate + 2 O2
?
-
-
-
?
(1R,2R)-(-)-2-(N-dichloroacetyl)-amino-1-(4-aminophenyl)-1,3-propanediol + reduced phenazine ethosulfate + 2 O2
?
-
-
-
?
(1R,2R)-(-)-2-(N-dichloroacetyl)-amino-1-(4-aminophenyl)-1,3-propanediol + reduced phenazine methosulfate + 2 O2
chloramphenicol + phenazine methosulfate + 2 H2O
-
-
-
?
(1R,2R)-(-)-2-(N-dichloroacetyl)-amino-1-(4-aminophenyl)-1,3-propanediol + reduced phenazine methosulfate + 2 O2
chloramphenicol + phenazine methosulfate + 2 H2O
-
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
physiological function
CmlI is a non-heme di-iron enzyme catalyzing N-oxygenation of an amine group, one of the steps in the biosynthesis of the antibiotic chloramphenicol
physiological function
diferrous CmlI can react with NH2-chloramphenicol species and O2 in either order to form a peroxo-NH2-chloramphenicol intermediate. Peroxo-NH2-chloramphenicol undergoes rapid oxygen transfer to form a diferric CmlI complex with the aryl-hydroxylamine [NH(OH)-chloramphenicol] pathway intermediate. Diferric CmlI-NH(OH)-chloramphenicol undergoes a rapid internal redox reaction to form a differous CmlI-nitroso-chloramphenicol complex. O2 binding results in formation of peroxo-NO-chloramphenicol that converts to differic CmlI-chloramphenicol by enzyme-mediated oxygen atom transfer. There is little dissociation of pathway intermediates as the reaction progresses
physiological function
during the catalytic cycle substrate N-[(1R,2R)-1-(4-aminophenyl)-1,3-dihydroxypropan-2-yl]-2,2-dichloroacetamide reacts with a long-lived peroxo intermediate to form a NH(OH)-chloramphenicol species and diferric CmlI. Then the NH(OH)-chloramphenicol re-reduces the enzyme diiron cluster, allowing the peroxo species to re-form upon O2 binding, while itself being oxidized to NO-chloramphenicol. Finally, the re-formed peroxo species oxidizes NO-chloramphenicol to chloramphenicol with incorporation of a second O2-derived oxygen atom. The complete six-electron oxidation requires only two exogenous electrons and may occur in one active site
physiological function
the key oxygenated intermediates in diiron arylamine oxygenases AurF, EC 1.14.99.68, and CmlI, so-called P, are uniformly hydroperoxo species having similar structures rather than the believed peroxo species. A diferric-hydroperoxo P is proposed to be able to promote the arylamine N-oxygenation with highly accessible kinetics
physiological function
-
diferrous CmlI can react with NH2-chloramphenicol species and O2 in either order to form a peroxo-NH2-chloramphenicol intermediate. Peroxo-NH2-chloramphenicol undergoes rapid oxygen transfer to form a diferric CmlI complex with the aryl-hydroxylamine [NH(OH)-chloramphenicol] pathway intermediate. Diferric CmlI-NH(OH)-chloramphenicol undergoes a rapid internal redox reaction to form a differous CmlI-nitroso-chloramphenicol complex. O2 binding results in formation of peroxo-NO-chloramphenicol that converts to differic CmlI-chloramphenicol by enzyme-mediated oxygen atom transfer. There is little dissociation of pathway intermediates as the reaction progresses
-
physiological function
-
during the catalytic cycle substrate N-[(1R,2R)-1-(4-aminophenyl)-1,3-dihydroxypropan-2-yl]-2,2-dichloroacetamide reacts with a long-lived peroxo intermediate to form a NH(OH)-chloramphenicol species and diferric CmlI. Then the NH(OH)-chloramphenicol re-reduces the enzyme diiron cluster, allowing the peroxo species to re-form upon O2 binding, while itself being oxidized to NO-chloramphenicol. Finally, the re-formed peroxo species oxidizes NO-chloramphenicol to chloramphenicol with incorporation of a second O2-derived oxygen atom. The complete six-electron oxidation requires only two exogenous electrons and may occur in one active site
-
physiological function
-
the key oxygenated intermediates in diiron arylamine oxygenases AurF, EC 1.14.99.68, and CmlI, so-called P, are uniformly hydroperoxo species having similar structures rather than the believed peroxo species. A diferric-hydroperoxo P is proposed to be able to promote the arylamine N-oxygenation with highly accessible kinetics
-
physiological function
-
CmlI is a non-heme di-iron enzyme catalyzing N-oxygenation of an amine group, one of the steps in the biosynthesis of the antibiotic chloramphenicol
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Komor, A.; Rivard, B.; Fan, R.; Guo, Y.; Que, L.; Lipscomb, J.
CmlI N-oxygenase catalyzes the final three steps in chloramphenicol biosynthesis without dissociation of intermediates
Biochemistry
56
4940-4950
2017
Streptomyces venezuelae (F2RB83), Streptomyces venezuelae DSM 40230 (F2RB83)
brenda
Makris, T.; Vu, V.; Meier, K.; Komor, A.; Rivard, B.; Muenck, E.; Que, L.; Lipscomb, J.
An unusual peroxo intermediate of the arylamine oxygenase of the chloramphenicol biosynthetic pathway
J. Am. Chem. Soc.
137
1608-1617
2015
Streptomyces venezuelae (F2RB83), Streptomyces venezuelae DSM 40230 (F2RB83)
brenda
Komor, A.; Rivard, B.; Fan, R.; Guo, Y.; Que, L.; Lipscomb, J.
Mechanism for six-electron aryl-N-oxygenation by the non-heme diiron enzyme CmlI
J. Am. Chem. Soc.
138
7411-7421
2016
Streptomyces venezuelae (F2RB83), Streptomyces venezuelae DSM 40230 (F2RB83)
brenda
Wang, C.; Chen, H.
Convergent theoretical prediction of reactive oxidant structures in diiron arylamine oxygenases AurF and CmlI peroxo or hydroperoxo?
J. Am. Chem. Soc.
139
13038-13046
2017
Streptomyces venezuelae (F2RB83), Streptomyces venezuelae DSM 40230 (F2RB83)
brenda
Knoot, C.; Kovaleva, E.; Lipscomb, J.
Crystal structure of CmlI, the arylamine oxygenase from the chloramphenicol biosynthetic pathway
J. Biol. Inorg. Chem.
21
589-603
2016
Streptomyces venezuelae (F2RB83), Streptomyces venezuelae DSM 40230 (F2RB83)
brenda
Lu, H.; Chanco, E.; Zhao, H.
CmlI is an N-oxygenase in the biosynthesis of chloramphenicol
Tetrahedron
68
7651-7654
2012
Streptomyces venezuelae (F2RB83), Streptomyces venezuelae DSM 40230 (F2RB83)
brenda